cjc-1295 legal: Frequently asked questions

Register as a business entity and establish a research-focused website or LLC documentation. Some suppliers will accept business registration plus a detailed research proposal as proof of legitimate non-clinical use. Expect additional verification steps. Including video calls or facility inspections for high-volume orders. And understand that not all suppliers will work with independent researchers regardless of documentation.

That's a compliance red flag. Legitimate research chemical suppliers implement verification protocols to avoid FDA enforcement action. A vendor willing to sell CJC-1295 to anyone without questions is either operating in a legal gray zone or actively violating federal regulations. The product itself may be genuine, but you're accepting risk that the supplier could be shut down, the product seized in transit, or worse. The peptide could be mislabeled or contaminated with zero legal recourse.

Customs and Border Protection (CBP) can seize packages containing research peptides if they're mislabeled, lack proper documentation, or arrive from countries with high counterfeit rates. You won't face criminal charges for a first-time personal-quantity seizure, but the product is permanently confiscated. File a petition for remission if you believe the seizure was erroneous, but expect months of processing time. The practical outcome: lost money and no product. This is why domestic sourcing from US-based suppliers like Real Peptides eliminates customs risk entirely.

That use is illegal in 2026. CJC-1295 is not approved for any human therapeutic indication, and personal use outside a clinical trial or physician-supervised IND protocol violates federal drug law. Gray-market suppliers that ship without requiring institutional documentation operate in violation of FDA regulations, and purchasing from such sources exposes you to product purity risk (no third-party verification), legal risk (possession of an unapproved drug), and in some states, misdemeanor criminal liability. The risk-benefit calculation for personal use is deeply unfavorable in 2026.

Yes, provided you have institutional affiliation and document non-human use intent. Suppliers like Real Peptides require purchase orders on institutional letterhead or proof of academic enrollment (graduate-level or above) before processing orders. You may also need to provide an IACUC protocol number if your institution requires it for peptide reagent purchases. The peptide itself remains fully legal to possess and use in laboratory settings. The restriction is on human therapeutic application, not research.

Yes. State-level bans on compounding CJC-1295 apply to licensed pharmacies preparing patient prescriptions. They do not restrict research chemical suppliers from shipping to institutional buyers within those states. A Texas-based university lab can still purchase CJC-1295 from a registered supplier despite Texas's compounding prohibition. The ban targets the therapeutic pipeline, not laboratory reagent access. However, individual possession without institutional affiliation may be treated differently depending on state enforcement priorities.

No. FDA guidance issued in March 2024 explicitly prohibited compounding pharmacies from preparing CJC-1295 for any patient prescription, regardless of prior prescribing history. Pharmacies that previously filled CJC-1295 prescriptions ceased doing so by mid-2024 to avoid enforcement action. If you have a standing prescription from 2023 or earlier, it cannot be legally refilled as of 2026. Some patients transitioned to FDA-approved growth hormone therapies or other approved peptides; others discontinued treatment entirely.